A demo

Lilly to buy cancer drug developer AurKa Pharma

May 15, 2018 , CNBC Health
Eli Lilly will buy AurKa Pharma in a deal potentially worth up to $575 million.

Read the full story...

Trending healthcare news keywords at this moment

rite aid merger drug cvs gene eye disease treatment exercise risk heart fda medical million opioid women cancer tied work teen study asthma tip kids patients medicare care people finds plans ceo scripts healthcare patient hospital medicaid boost growth brain doctors